Clinical Trial Update: Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the clinical utility and safety of pramlintide in adults with Type 1 and Type 2 diabetes has completed. The update highlights safety an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED